Retinal Pigment Epithelium Cell Production Through Sequential Culture

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current protocols for deriving retinal pigment epithelium (RPE) cells from pluripotent stem cells are labor-intensive and time-consuming, yielding limited quantities, which hampers their clinical application.

Innovation Solution

A method involving culturing pluripotent stem cells with a differentiating agent, followed by TGFβ superfamily member-containing medium, removing non-pigmented cells, and adherent surface culturing to generate an expanded population of RPE cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current protocols for deriving RPE cells from pluripotent stem cells are used, then RPE cells can be generated, but the process is labor-intensive and time-consuming with limited yield

Engineering Contradiction:

ImproveRPE cell yieldVSAvoidTime required for cell derivation

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The patent modifies culture medium composition by adding specific growth factors (bFGF, TGFβ, activin A) and adjusting culture conditions (adherent vs. non-adherent, oxygen levels) to optimize RPE cell differentiation and expansion, thereby increasing yield and reducing derivation time

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent implements a multi-step continuous process where pluripotent stem cells are first expanded, then differentiated through sequential media changes, and finally expanded again on adherent surfaces, maintaining continuous cell production rather than discrete batch processing

Inventive Principle:

Principle #20Continuity of useful action

2Ease of manufacture

If current protocols for deriving RPE cells are used, then RPE cells can be obtained, but the process requires extensive manual intervention and time

Engineering Contradiction:

ImproveProtocol simplicityVSAvoidCulture system complexity

Core Design Contradiction:

Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent divides the RPE cell derivation process into distinct stages: (1) pluripotent stem cell expansion in suspension, (2) differentiation in non-adherent culture with specific growth factors, and (3) expansion on adherent surfaces, making each step more manageable and optimizable

Inventive Principle:

Principle #1Segmentation

3Quantity of substance

If human fetal and adult RPE are used as donor sources, then RPE cells can be obtained for transplantation, but tissue supply is limited and ethical concerns arise

Engineering Contradiction:

ImproveDonor tissue availabilityVSAvoidEthical concerns and supply limitations

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent uses pluripotent stem cells that can self-renew and differentiate into RPE cells, creating an unlimited self-sustaining source that eliminates dependence on human fetal or adult donor tissues and resolves ethical supply limitations

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The patent changes the source material from finite human donor tissues to pluripotent stem cells with infinite self-renewal capacity, fundamentally altering the supply parameter from limited to unlimited while maintaining RPE cell functionality for transplantation

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method efficiently produces high-purity RPE cells suitable for clinical use, overcoming the limitations of existing protocols by increasing yield and reducing labor and time.

Implementation Method 1

culturing a population of human pluripotent stem cells in a medium comprising a differentiating agent to obtain differentiating cells

Methodology Applied

Scientific EffectDifferentiation:

Implementation Method 2

culturing the differentiating cells in a culture comprising a medium which comprises one or more members of the TGFβ superfamily

Methodology Applied

Scientific EffectTGFβ signaling:

Implementation Method 3

removing the mixed population of cells from the culture, wherein more than 10% of the cells of the mixed population of cells are non-pigmented cells

Methodology Applied

Scientific EffectCell separation:

Implementation Method 4

culturing the mixed population of cells on an adherent surface to generate an expanded population of RPE cells

Methodology Applied

Scientific EffectAdhesion: Adhesive

Data Source

PatentUS20250327026A1Preparation of retinal pigment epithelium cells

Publication Date: 2025.10.23 CELL CURE NEUROSCI

AI summary

A method of generating retinal pigment epithelium cells is disclosed. Cell populations comprising same and uses thereof are also disclosed.